A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.

Limited clinical benefits derived from anti-VEGF therapy have driven the identification of new targets involved in tumor angiogenesis. Here, we report an integrative meta-analysis to define the transcriptional program underlying angiogenesis in human cancer. This approach identified ELTD1, an orphan...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Masiero, M, Simões, F, Han, H, Snell, C, Peterkin, T, Bridges, E, Mangala, L, Wu, S, Pradeep, S, Li, D, Han, C, Dalton, H, Lopez-Berestein, G, Tuynman, J, Mortensen, N, Li, J, Patient, R, Sood, A, Banham, A, Harris, A, Buffa, F
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Elsevier 2013

A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis de réir Masiero, M, Simões, F, Han, H, Snell, C, Peterkin, T, Bridges, E, Mangala, L, Wu, S, Pradeep, S, Li, D, Han, C, Dalton, H, Lopez-Berestein, G, Tuynman, J, Mortensen, N, Li, J, Patient, R, Sood, A, Banham, A, Harris, A, Buffa, F

Foilsithe / Cruthaithe 2013

Journal article

A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.

Míreanna comhchosúla